ACYTE Biotech Pty Ltd is an Australian-based biotech company specializing in proprietary technology in mammalian cell engineering and cell culture. We provide cell line development for the cost-efficient production of therapeutic proteins in the biopharmaceutical industry. We aim to increase productivity and reduce costs.

ACYTE’s innovation is focused on the enhancement of productivity and yield in Chinese hamster ovary (CHO) cells. ACYTE’s proprietary technologies in CHO cell expression systems allows for the rapid generation of recombinant protein early in the drug development stage as well as the generation of high producing CHO cell lines for therapeutic production of recombinant protein.

Epi-CHO is ACYTE’s transient expression technology in CHO cells which is designed for large-scale transient production of therapeutic proteins for candidate molecule screening.

Super-CHO™ is ACYTE’s host cell line for the high-level and stable production of therapeutic proteins.

ACYTE has been successful in growing revenue by engaging in an increasing number of production contracts and collaborative agreements with major pharmaceutical and biotech companies.